Navigation Links
Europe Cardiac Surgery Device Market Value to Go Beyond USD 3.4 Bn by 2020, According to iData Research Study Available at MarketPublishers.com
Date:7/14/2014

London, UK (PRWEB) July 14, 2014

Europe’s market for cardiac surgery devices is projected to grow to over USD 3.4 billion by 2020, with the transcatheter heart valve devices sector (composed of the transcatheter heart valve implantation (THVI) and transcatheter mitral valve repair (TMVR) segments) fuelling this growth. The devices for transcatheter aortic valve implantation (TAVI) are ?urrently the only THVI product on the market. However, transcatheter mitral valve implantation (TMVI) devices are under development and are anticipated to get CE approval by end-2020.

With an ageing population and rising prevalence of obesity, the number of patients suffering from heart failure in Europe will likely keep on growing. Mitral regurgitation (MR) affects millions of people all over the world and it is the second most common heart valve disease in Europe. Due to its minimal invasiveness, TMVR is a more attractive treatment option to patients suffering from MR compared to open surgery. The market is projected to grow to over 12% in 2020. Abbott with their MitraClip™ (the first TMVR device in the world) and Cardiac Dimensions are currently the only players in this market space. The market for THVI devices (consisting of the transcathether mitral valve implantation (TMVI) and transcatheter aortic valve implantation (TAVI)) is expected to post 10% growth through to 2020. As of 2013, only TAVI products received approval in Europe. Edwards Lifesciences with their novel product SAPIEN 3®, Boston Scientific with their Lotus™ Valve System, Medtronic, JenaValve, St. Jude Medical, Direct Flow Medical and Sorin are dominating the TAVI market.

Recent advancements in the treatment of aortic heart valve diseases have been instigating profound interest amid the global cardiac community. Biological valves (or tissue valves) belong within newer and less invasive treatment options for aortic heart valve conditions compared to the conve
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cancer Care Costs Higher in U.S. Than Europe, But Survival Longer
2. Life expectancy and healthy life years in the European Union, 2008-2010
3. U.S. Bests Canada, Europe in Drug Approvals
4. Coronary rehabilitation programs in Europe are underused
5. ESC says 50 percent of CVD deaths in Europe could be avoided with proper regulation
6. Leading cancer specialists from Europe and beyond recognized at ESMO 2012
7. ESC analysis reveals arrhythmia treatment gaps between Eastern and Western Europe
8. SAGE to launch United European Gastroenterology Journal
9. First comprehensive review of European breast cancer screening programs finds benefits outweigh harm
10. Biggest European health study identifies key priorities in 26 cities
11. BMJ and Daily Telegraphs fake hip exposes failing European device regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... The microscopy market is estimated ... reach $5,756.0 million by 2019. Optical microscopy is ... electron microscopes product segment is expected to show ... Rising focus on nanotechnology, technological advancements, and increasing ... market. , Get Full Copy of Report @ ...
(Date:12/25/2014)... The click strand woven bamboo flooring ... the business announces a click strand woven bamboo ... 2015. , Click strand woven bamboo flooring replicates ... well-known brand in the bamboo industry. It promises ... bamboo flooring supplier. , “We are happy to ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 The report ... 2023” focuses on the current treatment landscape, unmet needs, ... market. TS-1 is an anti-cancer drug which is typically ... and is also used for treating gastric cancer and ... otastat potassium. The drug was first approved in 1999 ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... 2014 Recently, Dylan Queen, a famous ... released its collection of discounted prom dresses, most of ... senior spokesman of the company, the promotion is valid ... is to expand the UK market. , The prom ... colors, lengths, and styles: A-line strapless, empire strapless chiffon, ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... International Cancer Research team has come out with the startling ... development of tumors in mice. This discovery could be vital ... molecules work by blocking the hormones that are essential for ... they strangle the tumor by blocking blood and nutrient supply ...
... turning their backs on tanning amid growing concerns over skin ... survey shows that teenagers are resisting the urge to tan ... 5,073 Australian adults and 699 Australian teenagers aged 12 to ... that 68 % of those aged 12-17 said they had ...
... part of the school curriculum from Class IX in all ... the age of 25. The new curriculum would be made ... the Human Resource Department of Government of India and National ... ministry has also made it compulsory to train teachers on ...
... have reacted with skepticism to a British man's claims that he ... some relief. // , ,In what is assumed as a ... now available in India. , ,This medicine is provided in ... that it would help the infected people to lead a much ...
... are unconcerned with the effect of their habit on the ... the damage // that smoking caused to the tongue or ... strangely reluctant to change their habits. This is of particular ... a massive awareness campaign as a part of the Mouth ...
... a doctor's permission is good at any time of life, ... study. // ,Thomas Foster and other scientists from the McKnight ... of rats that had lived to old age. Some were ... , ,Scientists examined chemical compounds in 41 tissue samples ...
Cached Medicine News:Health News:Aussie teens applauded for declining sun tan 2Health News:Regular light exercise slows down aging of the brain 2
(Date:12/22/2014)... 22, 2014 Research and Markets ... the "Investment Analysis of the US Medical ... http://photos.prnewswire.com/prnh/20130307/600769 ... medical device sector identifies the key trends and ... investments, and mergers and acquisitions. The ...
(Date:12/22/2014)... Pa. and STOCKHOLM , ... (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today announced ... (CHMP) of the European Medicines Agency (EMA) has adopted ... clostridium histolyticum) for the treatment of adult men with ... of at least 30 degrees at the start of ...
(Date:12/22/2014)... 22, 2014  Eiger BioPharmaceuticals Incorporated announced the ... lonafarnib in patients with chronic hepatitis delta virus ... National Institutes of Health (NIH) Clinical Center in ... randomized, placebo-controlled, dose ascending study evaluated two doses ... mg twice daily for 28 days.  "This proof-of-concept ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... (Pink Sheets: MDBX ) ( www.thedispensingsolution.com ), ... to MDBX.  The company previously announced that their name ... The company is a leader in the design, manufacture ... The free-standing unit features 60 or more slots that ...
... 2011 This year, the melanoma community saw the first ... This major step forward will give more than 400 party-goers ... Gala.  They will gather at the Trump National Golf Club ... these cutting-edge advances and raise money for future research through ...
Cached Medicine Technology:MedBox Announces Ticker Symbol Change 2Washington, D.C. Melanoma Patient Community Celebrates Treatment Advances 2Washington, D.C. Melanoma Patient Community Celebrates Treatment Advances 3
Cushing-Hopkins periosteal elevator, Gutsch handle, blade width 7/16" (11 mm), length 7 5/8" (194 mm)....
Barr periosteal elevators....
Seldin periosteal elevators....
Williger periosteal elevators....
Medicine Products: